State Street’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,885,944
Closed -$122M 4649
2023
Q2
$122M Buy
2,885,944
+31,564
+1% +$1.28M 0.01% 1090
2023
Q1
$102M Buy
2,854,380
+46,991
+2% +$1.71M 0.01% 1176
2022
Q4
$103M Buy
2,807,389
+101,109
+4% +$4M 0.01% 1143
2022
Q3
$128M Buy
2,706,280
+45,731
+2% +$2.95M 0.01% 965
2022
Q2
$191M Buy
2,660,549
+129
+0% +$9.43K 0.01% 761
2022
Q1
$215M Buy
2,660,420
+61,351
+2% +$5.19M 0.01% 796
2021
Q4
$267M Buy
2,599,069
+82,093
+3% +$7.88M 0.01% 728
2021
Q3
$220M Buy
2,516,976
+67,483
+3% +$6.11M 0.01% 785
2021
Q2
$219M Buy
2,449,493
+619,006
+34% +$52.3M 0.01% 805
2021
Q1
$139M Buy
1,830,487
+183,664
+11% +$13.8M 0.01% 994
2020
Q4
$112M Buy
1,646,823
+165,512
+11% +$10.3M 0.01% 1059
2020
Q3
$78.7M Buy
1,481,311
+4,895
+0.3% +$291K 0.01% 1132
2020
Q2
$86M Sell
1,476,416
-506,022
-26% -$27.2M 0.01% 1070
2020
Q1
$78.1M Sell
1,982,438
-11,396
-0.6% -$666K 0.01% 979
2019
Q4
$119M Sell
1,993,834
-14,818
-0.7% -$797K 0.01% 938
2019
Q3
$107M Sell
2,008,652
-131,305
-6% -$6.74M 0.01% 964
2019
Q2
$109M Buy
2,139,957
+52,574
+3% +$2.45M 0.01% 981
2019
Q1
$108M Buy
2,087,383
+61,911
+3% +$3M 0.01% 958
2018
Q4
$79.7M Sell
2,025,472
-95,376
-4% -$4.43M 0.01% 1038
2018
Q3
$109M Buy
2,120,848
+179,938
+9% +$8.81M 0.01% 1013
2018
Q2
$91M Buy
1,940,910
+117,440
+6% +$4.86M 0.01% 1103
2018
Q1
$64.7M Sell
1,823,470
-249,499
-12% -$9.77M 0.01% 1263
2017
Q4
$90.4M Buy
2,072,969
+213,972
+12% +$10M 0.01% 1084
2017
Q3
$97.2M Buy
1,858,997
+89,644
+5% +$5M 0.01% 997
2017
Q2
$104M Buy
1,769,353
+937,864
+113% +$48.7M 0.01% 953
2017
Q1
$38.1M Buy
831,489
+6,742
+0.8% +$335K ﹤0.01% 1490
2016
Q4
$43.4M Buy
824,747
+58,549
+8% +$2.83M ﹤0.01% 1353
2016
Q3
$34.2M Buy
766,198
+71,814
+10% +$3.11M ﹤0.01% 1431
2016
Q2
$26.5M Buy
694,384
+393,144
+131% +$17.3M ﹤0.01% 1554
2016
Q1
$12.4M Buy
301,240
+9,348
+3% +$385K ﹤0.01% 2044
2015
Q4
$14.2M Buy
291,892
+8,238
+3% +$366K ﹤0.01% 1971
2015
Q3
$11.3M Buy
283,654
+96,255
+51% +$4.2M ﹤0.01% 2104
2015
Q2
$7.52M Buy
187,399
+79,783
+74% +$2.75M ﹤0.01% 2421
2015
Q1
$3.52M Buy
107,616
+33,072
+44% +$913K ﹤0.01% 2760
2014
Q4
$1.92M Buy
+74,544
New +$1.77M ﹤0.01% 3064

Other funds holding SYNH

State Street's SYNH Position: Q3 2023 in Review

State Street sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 2,885,944 shares — an estimated $122M sold.

State Street first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $267M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • State Street reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • State Street sold 2,885,944 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $122M.
  • State Street first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
  • State Street's Syneos Health, Inc. Class A Common Stock position peaked at $267M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.